A rapid phenotypic assay for detection of acyclovir-resistant varicella- zoster virus with mutations in the thymidine kinase open reading frame

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 4, 2000, Pages 873-878

  Sahli, Roland ^a   Andrei, Graciela ^b   Estrade, Christine ^a   Snoeck, Robert ^b   Meylan, Pascal R A ^a  

^a Institute of Microbiology   (Switzerland)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPICILLIN; FLOXURIDINE; THYMIDINE KINASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM TRANSFORMATION; BIOASSAY; CEREBROSPINAL FLUID CULTURE; GENE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VALIDATION PROCESS; VARICELLA ZOSTER VIRUS; VIRUS DETECTION;

ACYCLOVIR; ANTIVIRAL AGENTS; CHICKENPOX; CLONING, MOLECULAR; ESCHERICHIA COLI; FLOXURIDINE; HERPESVIRUS 3, HUMAN; HUMANS; MUTATION; OPEN READING FRAMES; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDINE KINASE;

EID: 0034059814     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.4.873-878.2000     Document Type: Article

References (46)

1. Agut, H., J. T. Aubin, D. Ingrand, S. Blanc, A. L. Clayton, S. M. Chantler, and J. M. Huraux. 1990. Simplified test for detecting the resistance of herpes simplex virus to acyclovir. J. Med. Virol. 31:209-214.
2. Arvin, A. M. 1996. Varicella-zoster virus. Clin. Microbiol. Rev. 9:361-381.
3. Boivin, G., C. K. Edelman, L. Pedneault, C. L. Talarico, K. K. Biron, and H. H. Balfour, Jr. 1994. Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS. J. Infect. Dis. 170:68-75.
4. Breton, G., A. M. Fillet, C. Katlama, F. Bricaire, and E. Caumes. 1998. Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy. Clin. Infect. Dis. 27:1525-1527.
5. Chatis, P. A., and C. S. Crumpacker. 1991. Analysis of the thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex viruses. Virology 180:793-797.
6. Chatis, P. A., and C. S. Crumpacker. 1992. Resistance of herpesviruses to antiviral drugs. Antimicrob. Agents Chemother. 36:1589-1595.
7. Christophers, J., J. Clayton, J. Craske, R. Ward, P. Collins, M. Trowbridge, and G. Darby. 1998. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob. Agents Chemother. 42:868-872.
8. Coen, D. M. 1996. Nucleosides and foscarnet - mechanism, p. 81-102. In D. D. Richman (ed.), Antiviral drug resistance. John Wiley & Sons Ltd., Chichester, England.
9. Collins, P., B. A. Larder, N. M. Oliver, S. Kemp, I. W. Smith, and G. Darby. 1989. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J. Gen. Virol. 70(Pt. 2):375-382.
10. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67(Pt. 9):1759-1816.
11. de la Iglesia, P., S. Melon, B. Lopez, M. Rodriguez, M. I. Blanco, P. Mellado, and M. de Ona. 1998. Rapid screening tests for determining in vitro susceptibility of herpes simplex virus clinical isolates. J. Clin. Microbiol. 36:2389-2391.
12. Ellis, M. N., P. M. Keller, J. A. Fyfe, J. L. Martin, J. F. Rooney, S. E. Straus, S. N. Lehrman, and D. W. Barry. 1987. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob. Agents Chemother. 31:1117-1125.
13. Fillet, A. M., B. Dumont, E. Caumes, B. Visse, H. Agut, F. Bricaire, and J. M. Huraux. 1998. Acyclovir-resistant varicella-zoster virus - phenotypic and genetic characterization. J. Med. Virol. 55:250-254.
14. Fillet, A. M., B. Visse, E. Caumes, B. Dumont, M. Gentilini, and J. M. Huraux. 1995. Foscarnet-resistant multidermatomal zoster in a patient with AIDS. Clin. Infect. Dis. 21:1348-1349.
15. Gaudreau, A., E. Hill, H. H. Balfour, A. Erice, and G. Boivin. 1998. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J. Infect. Dis. 178:297-303.
16. Gershon, A. A., and B. Forghani. 1995. Varicella-zoster virus, p. 601-613. In E. H. Lennette, D. A. Lennette, and E. T. Lennette (ed.). Diagnostic procedures for viral, rickettsial, and chlamydial infections. American Public Health Association, Washington, D.C.
17. Gershon, A. A., and S. J. Silverstein. 1997. Varicella-zoster virus, p. 421-444. In D. D. Richman, R. J. Whitley, and F. G. Hayden (ed.), Clinical virology. Churchill Livingstone Inc., New York, N. Y.
18. Hammer, S. M., and R. T. Inouye. 1997. Antiviral agents, p. 185-250. In D. D. Richman, R. J. Whitley, and F. G. Hayden (ed.). Clinical virology. Churchill Livingstone Inc., New York, N.Y.
19. Hill, E. L., G. A. Hunter, and M. N. Ellis. 1991. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 35:2322-2328.
20. Hoppenjans, W. B., M. R. Bibler, R. L. Orme, and A. M. Solinger. 1990. Prolonged cutaneous herpes zoster in acquired immunodeficiency syndrome. Arch. Dermatol. 126:1048-1050.
21. Jacobson, M. A., T. G. Berger, S. Fikrig, P. Becherer, J. W. Moohr, S. C. Stanat, and K. K. Biron. 1990. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 112:187-191.
22. Lacey, S. F., T. Suzutani, K. L. Powell, D. J. Purifoy, and R. W. Honess. 1991 Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction. J. Gen. Virol. 72:623-630.
23. Linnemann, C. C. J., K. K. Biron, W. G. Hoppenjans, and A. M. Solinger. 1990. Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy. AIDS 4:577-579.
24. Lokke, J., K. Weismann, L. Mathiesen, and T. Klem. 1993. Atypical varicella-zoster infection in AIDS. Acta Dermato-Venereol. 73:123-125.
25. Meylan, P. R., J. Miklossy, A. Iten, C. Petignat, R. Meuli, J. Zufferey, and R. Sahli. 1995. Myelitis due to varicella-zoster virus in an immunocompromised patient without a cutaneous rash. Clin. Infect. Dis. 20:206-208.
26. Morfin, F., D. Thouvenot, M. Turenne-Tessier, B. Lina, M. Aymard, and T. Ooka. 1999. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir. Antimicrob. Agents Chemother. 43:2412-2416.
27. Nugier, F., J. N. Colin, M. Aymard, and M. Langlois. 1992. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J. Med. Virol. 36:1-12.
28. Pahwa, S., K. Biron, W. Lim, P. Swenson, M. H. Kaplan, N. Sadick, and R. Parma. 1988. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. JAMA 260:2879-2882.
29. Parker, A. C., J. I. Craig, P. Collins, N. Oliver, and I. Smith. 1987. Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase. Lancet ii:1461.
30. Roberts, G. B., J. A. Fyfe, R. K. Gaillard, and S. A. Short. 1991. Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment. J. Virol. 65:6407-6413.
31. Sacks, S. L., R. J. Wanklin, D. E. Reece, K. A. Hicks, K. L. Tyler, and D. M. Coen. 1989. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? Ann. Intern. Med. 111:893-899.
32. Safrin, S. 1996. Nucleosides and foscarnet - clinical aspects, p. 103-122. In D. D. Richman (ed.), Antiviral drug resistance. John Wiley & Sons Ltd., Chichester, England.
33. Safrin, S., T. G. Berger, I. Gilson, P. R. Wolfe, C. B. Wofsy, J. Mills, and K. K. Biron. 1991. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann. Intern. Med. 115:19-21.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Preparation and transformation of competent E. coli, p. 1.82-1.84. In J. Sambrook, E. F. Fritsch, and T. Maniatis (ed.), Molecular cloning: a laboratory manual, vol. 1 ,2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Sasadeusz, J. J., F. Tufaro, S. Safrin, K. Schubert, M. M. Hubinette, P. K. Cheung, and S. L. Sacks. 1997. Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J. Virol. 71:3872-3878.
36. Sawyer, M. H., G. Inchauspe, K. K. Biron, D. J. Waters, S. E. Straus, and J. M. Ostrove. 1988. Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus. J. Gen. Virol. 69:2585-2593.
37. Snoeck, R., M. Gerard, C. Sadzot-Delvaux, G. Andrei, J. Balzarini, D. Reymen, N. Ahadi, J. M. De Bruyn, J. Piette, and B. Rentier. 1994. Meningoradiculoneuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient. J. Med. Virol. 42:338-347.
38. Standring-Cox, R., T. H. Bacon, and B. A. Howard. 1996. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir. J. Virol. Methods 56:3-11.
39. Summers, W. C., and P. Raksin. 1993. A method for selection of mutations at the tdk locus in Escherichia coli. J. Bacteriol. 175:6049-6051.
40. Suzutani, T., S. F. Lacey, K. L. Powell, D. J. Purifoy, and R. W. Honess. 1992. Random mutagenesis of the thymidine kinase gene of varicella-zoster virus. J. Virol. 66:2118-2124.
41. Swierkosz, E. M., D. R. Scholl, J. L. Brown, J. D. Jollick, and C. A. Gleaves. 1987. Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus. Antimicrob. Agents Chemother. 31:1465-1469.
42. Talarico, C. L., W. C. Phelps, and K. K. Biron. 1993. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS. J. Virol. 67:1024-1033.
43. Tappero, J. W., B. A. Perkins, J. D. Wenger, and T. G. Berger. 1995. Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus. Clin. Microbiol. Rev. 8:440-450.
44. Tebas, P., D. Scholl, J. Jollick, K. McHarg, M. Arens, and P. D. Olivo. 1998. A rapid assay to screen for drug-resistant herpes simplex virus. J. Infect. Dis. 177:217-220.
45. Whitley, R. J., and B. Roizman. 1997. Herpes simplex viruses, p. 375-410. In D. D. Richman, R. J. Whitley, and F. G. Hayden (ed.), Clinical virology. Churchill Livingstone Inc., New York, N.Y.
46. Wunderli, W., R. Miner, J. Wintsch, S. Vongunten, H. H. Hirsch, and B. Hirschel. 1996. Outer retinal necrosis due to a strain of varicella-zoster virus resistant to acyclovir, ganciclovir, and sorivudine. Clin. Infect. Dis. 22:864-865.